Monitoring nevirapine-based programmes for prevention of mother-to-child transmission of HIV-1. Stringer JS, Sinkala M, Goldenberg R, Vermund S, Acosta E (2003) Lancet 362: 667 Zambian women's attitudes toward mass nevirapine therapy to prevent perinatal transmission of HIV. Sinkala M, Stout JP, Vermund SH, Goldenberg RL, Stringer JS (2001) Lancet 358: 1611-2 Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Kuhn L, Kasonde P, Sinkala M, Kankasa C, Semrau K, Scott N, Tsai WY, Vermund SH, Aldrovandi GM, Thea DM (2005) Clin Infect Dis 41: 1654-61 Effects on mortality of a nutritional intervention for malnourished HIV-infected adults referred for antiretroviral therapy: a randomised controlled trial. NUSTART (Nutritional Support for Africans Starting Antiretroviral Therapy) Study Team, Filteau S, PrayGod G, Kasonka L, Woodd S, Rehman AM, Chisenga M, Siame J, Koethe JR, Changalucha J, Michael D, Kidola J, Manno D, Larke N, Yilma D, Heimburger DC, Friis H, Kelly P (2015) BMC Med 13: 17 Early immunologic response and subsequent survival among malnourished adults receiving antiretroviral therapy in Urban Zambia. Koethe JR, Limbada MI, Giganti MJ, Nyirenda CK, Mulenga L, Wester CW, Chi BH, Stringer JS (2010) AIDS 24: 2117-21 Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia. Mwanahamuntu MH, Sahasrabuddhe VV, Pfaendler KS, Mudenda V, Hicks ML, Vermund SH, Stringer JS, Parham GP (2009) AIDS 23: N1-5 Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia. Stringer EM, Sinkala M, Stringer JS, Mzyece E, Makuka I, Goldenberg RL, Kwape P, Chilufya M, Vermund SH (2003) AIDS 17: 1377-82 Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settings. Stringer JS, Sinkala M, Goldenberg RL, Kumwenda R, Acosta EP, Aldrovandi GM, Stout JP, Vermund SH (2004) AIDS 18: 939-43 Transitioning HIV care and treatment programs in southern Africa to full local management. Vermund SH, Sidat M, Weil LF, Tique JA, Moon TD, Ciampa PJ (2012) AIDS 26: 1303-10 Treatment of intestinal helminths does not reduce plasma concentrations of HIV-1 RNA in coinfected Zambian adults. Modjarrad K, Zulu I, Redden DT, Njobvu L, Lane HC, Bentwich Z, Vermund SH (2005) J Infect Dis 192: 1277-83 Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, Huh WK, Lyon MD, Stringer JS, Parham GP (2007) Br J Cancer 96: 1480-3 An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs. Chi BH, Cantrell RA, Mwango A, Westfall AO, Mutale W, Limbada M, Mulenga LB, Vermund SH, Stringer JS (2010) Am J Epidemiol 171: 924-31 Priorities for antiretroviral therapy research in sub-Saharan Africa: a 2002 consensus conference in Zambia. Zulu I, Schuman P, Musonda R, Chomba E, Mwinga K, Sinkala M, Chisembele M, Mwaba P, Kasonde D, Vermund SH (2004) J Acquir Immune Defic Syndr 36: 831-4 Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings. Stringer JS, Sinkala M, Stout JP, Goldenberg RL, Acosta EP, Chapman V, Kumwenda-Phiri R, Vermund SH (2003) J Acquir Immune Defic Syndr 32: 506-13 Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, Zambia. Bateman AC, Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Kapambwe S, Katundu K, Nkole T, Mulundika J, Pfaendler KS, Hicks ML, Shibemba A, Vermund SH, Stringer JS, Chibwesha CJ (2014) J Acquir Immune Defic Syndr 67: 212-5 Personal risk perception, HIV knowledge and risk avoidance behavior, and their relationships to actual HIV serostatus in an urban African obstetric population. Stringer EM, Sinkala M, Kumwenda R, Chapman V, Mwale A, Vermund SH, Goldenberg RL, Stringer JS (2004) J Acquir Immune Defic Syndr 35: 60-6 A comparison of HIV detection rates using routine opt-out provider-initiated HIV testing and counseling versus a standard of care approach in a rural African setting. Silvestri DM, Modjarrad K, Blevins ML, Halale E, Vermund SH, McKinzie JP (2011) J Acquir Immune Defic Syndr 56: e9-32 Implementation and Operational Research: Age Distribution and Determinants of Invasive Cervical Cancer in a "Screen-and-Treat" Program Integrated With HIV/AIDS Care in Zambia. Kapambwe S, Sahasrabuddhe VV, Blevins M, Mwanahamuntu MH, Mudenda V, Shepherd BE, Chibwesha CJ, Pfaendler KS, Hicks ML, Vermund SH, Stringer JS, Parham GP (2015) J Acquir Immune Defic Syndr 70: e20-6 Effects on anthropometry and appetite of vitamins and minerals given in lipid nutritional supplements for malnourished HIV-infected adults referred for antiretroviral therapy: results from the NUSTART randomized controlled trial. Rehman AM, Woodd S, PrayGod G, Chisenga M, Siame J, Koethe JR, Heimburger DC, Kelly P, Friis H, Filteau S (2015) J Acquir Immune Defic Syndr 68: 405-12 Nutrition and inflammation serum biomarkers are associated with 12-week mortality among malnourished adults initiating antiretroviral therapy in Zambia. Koethe JR, Blevins M, Nyirenda C, Kabagambe EK, Shepherd BE, Wester CW, Zulu I, Chiasera JM, Mulenga LB, Mwango A, Heimburger DC (2011) J Int AIDS Soc 14: 19 Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, Stringer EM, Vermund SH (2006) Gynecol Oncol 103: 1017-22 Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. Pfaendler KS, Mwanahamuntu MH, Sahasrabuddhe VV, Mudenda V, Stringer JS, Parham GP (2008) Gynecol Oncol 110: 402-7 Pediatric malignancies, treatment outcomes and abandonment of pediatric cancer treatment in Zambia. Slone JS, Chunda-Liyoka C, Perez M, Mutalima N, Newton R, Chintu C, Kankasa C, Chipeta J, Heimburger DC, Vermund SH, Friedman DL (2014) PLoS One 9: e89102 Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia. Mwanahamuntu MH, Sahasrabuddhe VV, Blevins M, Kapambwe S, Shepherd BE, Chibwesha C, Pfaendler KS, Mkumba G, Vwalika B, Hicks ML, Vermund SH, Stringer JS, Parham GP (2013) PLoS One 8: e74607 A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristics. Koethe JR, Westfall AO, Luhanga DK, Clark GM, Goldman JD, Mulenga PL, Cantrell RA, Chi BH, Zulu I, Saag MS, Stringer JS (2010) PLoS One 5: e9680 Serum phosphate predicts early mortality in adults starting antiretroviral therapy in Lusaka, Zambia: a prospective cohort study. Heimburger DC, Koethe JR, Nyirenda C, Bosire C, Chiasera JM, Blevins M, Munoz AJ, Shepherd BE, Potter D, Zulu I, Chisembele-Taylor A, Chi BH, Stringer JS, Kabagambe EK (2010) PLoS One 5: e10687 Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia. Parham GP, Mwanahamuntu MH, Kapambwe S, Muwonge R, Bateman AC, Blevins M, Chibwesha CJ, Pfaendler KS, Mudenda V, Shibemba AL, Chisele S, Mkumba G, Vwalika B, Hicks ML, Vermund SH, Chi BH, Stringer JS, Sankaranarayanan R, Sahasrabuddhe VV (2015) PLoS One 10: e0122169 The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study. Bateman AC, Katundu K, Mwanahamuntu MH, Kapambwe S, Sahasrabuddhe VV, Hicks ML, Chi BH, Stringer JS, Parham GP, Chibwesha CJ (2015) BMC Cancer 15: 541 A 12 week longitudinal study of microbial translocation and systemic inflammation in undernourished HIV-infected Zambians initiating antiretroviral therapy. Canipe A, Chidumayo T, Blevins M, Bestawros M, Bala J, Kelly P, Filteau S, Shepherd BE, Heimburger DC, Koethe JR (2014) BMC Infect Dis 14: 521 Prevalence and predictors of intestinal helminth infections among human immunodeficiency virus type 1-infected adults in an urban African setting. Modjarrad K, Zulu I, Redden DT, Njobvu L, Freedman DO, Vermund SH (2005) Am J Trop Med Hyg 73: 777-82 Appetite testing in HIV-infected African adults recovering from malnutrition and given antiretroviral therapy. Rehman AM, Woodd S, Chisenga M, Siame J, Sampson G, PrayGod G, Koethe JR, Kelly P, Filteau S (2015) Public Health Nutr 18: 742-51 Self-reported dietary intake and appetite predict early treatment outcome among low-BMI adults initiating HIV treatment in sub-Saharan Africa. Koethe JR, Blevins M, Bosire C, Nyirenda C, Kabagambe EK, Mwango A, Kasongo W, Zulu I, Shepherd BE, Heimburger DC (2013) Public Health Nutr 16: 549-58 Cardiometabolic risk factors among HIV patients on antiretroviral therapy. Kiage JN, Heimburger DC, Nyirenda CK, Wellons MF, Bagchi S, Chi BH, Koethe JR, Arnett DK, Kabagambe EK (2013) Lipids Health Dis 12: 50 Monitoring the performance of "screen-and-treat" cervical cancer prevention programs. Mwanahamuntu MH, Sahasrabuddhe VV, Blevins M, Kapambwe S, Shepherd BE, Chibwesha C, Pfaendler KS, Mkumba G, Vwalika B, Hicks ML, Vermund SH, Stringer JSA, Parham GP (2014) Int J Gynaecol Obstet 126: 88-89 The Effect of Cryotherapy on Human Papillomavirus Clearance Among HIV-Positive Women in Lusaka, Zambia. Katundu K, Bateman AC, Pfaendler KS, Mwanahamuntu MH, Kapambwe S, Vermund SH, Sahasrabuddhe VV, Msadabwe SC, Stringer JS, Parham GP, Chibwesha CJ (2015) J Low Genit Tract Dis 19: 301-6 eC3--a modern telecommunications matrix for cervical cancer prevention in Zambia. Parham GP, Mwanahamuntu MH, Pfaendler KS, Sahasrabuddhe VV, Myung D, Mkumba G, Kapambwe S, Mwanza B, Chibwesha C, Hicks ML, Stringer JS (2010) J Low Genit Tract Dis 14: 167-73
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.